A citation-based method for searching scientific literature

Lekha Mikkilineni, James N Kochenderfer. Nat Rev Clin Oncol 2021
Times Cited: 68



Adrienne H Long, Waleed M Haso, Jack F Shern, Kelsey M Wanhainen, Meera Murgai, Maria Ingaramo, Jillian P Smith, Alec J Walker, M Eric Kohler, Vikas R Venkateshwara, Rosandra N Kaplan, George H Patterson, Terry J Fry, Rimas J Orentas, Crystal L Mackall. Nat Med 2015
Times Cited: 844




List of shared articles



Times cited

Engineering enhanced CAR T-cells for improved cancer therapy.
Michael C Milone, Jie Xu, Sai-Juan Chen, McKensie A Collins, Jianfeng Zhou, Daniel J Powell, J Joseph Melenhorst. Nat Cancer 2021
10

Novel two-chain structure utilizing KIRS2/DAP12 domain improves the safety and efficacy of CAR-T cells in adults with r/r B-ALL.
Ming Sun, Peipei Xu, Enxiu Wang, Min Zhou, Tongpeng Xu, Jing Wang, Qian Wang, Bo Wang, Kaihua Lu, Chen Wang,[...]. Mol Ther Oncolytics 2021
2


Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells.
Hongxia Wang, Liyan Wang, Yanning Li, Guangqi Li, Xiaochun Zhang, Dan Jiang, Yanting Zhang, Liyuan Liu, Yuankui Chu, Guangxian Xu. Cancer Cell Int 2021
3

Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma.
Siler H Panowski, Surabhi Srinivasan, Nguyen Tan, Silvia K Tacheva-Grigorova, Bryan Smith, Yvonne S L Mak, Hongxiu Ning, Jonathan Villanueva, Dinali Wijewarnasuriya, Shanshan Lang,[...]. Cancer Res 2022
1

A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.
Kathryn M Cappell, James N Kochenderfer. Nat Rev Clin Oncol 2021
27

IL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation.
Anthony M Battram, Mireia Bachiller, Victor Lopez, Carlos Fernández de Larrea, Alvaro Urbano-Ispizua, Beatriz Martín-Antonio. Cancers (Basel) 2021
4